203 related articles for article (PubMed ID: 22057239)
21. Stomach antral endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Hatlebakk JG; Hausken T
Int J Mol Med; 2014 Oct; 34(4):967-74. PubMed ID: 25110039
[TBL] [Abstract][Full Text] [Related]
22. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease.
Wendelbo I; Mazzawi T; El-Salhy M
Mol Med Rep; 2014 Jan; 9(1):180-4. PubMed ID: 24213511
[TBL] [Abstract][Full Text] [Related]
23. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Gundersen D; Hausken T
World J Gastrointest Endosc; 2014 May; 6(5):176-85. PubMed ID: 24891930
[TBL] [Abstract][Full Text] [Related]
24. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
El-Salhy M; Lomholt-Beck B; Hausken T
Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
[TBL] [Abstract][Full Text] [Related]
26. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Wendelbo IH; Gundersen D
Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
[TBL] [Abstract][Full Text] [Related]
27. Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation.
Camilleri M; Magnus Y; Carlson P; Wang XJ; Chedid V; Maselli D; Taylor A; McKinzie S; Kengunte Nagaraj N; Busciglio I; Nair A
Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G88-G101. PubMed ID: 35502856
[TBL] [Abstract][Full Text] [Related]
28. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
29. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
[TBL] [Abstract][Full Text] [Related]
30. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
31. Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance.
Qin B; Dong L; Guo X; Jiang J; He Y; Wang X; Li L; Zhao J
Int J Clin Exp Pathol; 2014; 7(5):2238-46. PubMed ID: 24966932
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E
Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
[TBL] [Abstract][Full Text] [Related]
33. Close association between abnormal expressed enzymes of energy metabolism and diarrhea-predominant irritable bowel syndrome.
Zhang CY; Yao X; Sun G; Yang YS
Chin Med J (Engl); 2019 Jan; 132(2):135-144. PubMed ID: 30614852
[TBL] [Abstract][Full Text] [Related]
34. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
[TBL] [Abstract][Full Text] [Related]
35. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
[TBL] [Abstract][Full Text] [Related]
36. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
Scand J Gastroenterol; 2017; 52(6-7):691-697. PubMed ID: 28346031
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV
Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627
[TBL] [Abstract][Full Text] [Related]
38. Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
Sikander A; Rana SV; Prasad KK
Clin Chim Acta; 2009 May; 403(1-2):47-55. PubMed ID: 19361459
[TBL] [Abstract][Full Text] [Related]
39. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
[TBL] [Abstract][Full Text] [Related]
40. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome.
Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV
Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
